MedTrace Logo

LithoVue Elite Registry

NCT05201456 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-12-18

No results posted yet for this study

Summary

To obtain postmarket safety and efficacy data on Boston Scientific LithoVue™ Elite System.

Conditions

  • Kidney Stone
  • Urolithiasis

Interventions

DEVICE

LithoVue Elite System

The LithoVue Elite System is intended to be used to visualize organs, cavities and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) via transurethral or percutaneous access routes. It can also be used in conjunction with endoscopic accessories to perform various diagnostic and therapeutic procedures in the urinary tract.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Ben Chew · Vancouver General Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-04-01
Completion
2023-12-01
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201456 on ClinicalTrials.gov